The 40-gene Expression Profile (40-GEP) Test Identifies Cutaneous Squamous Cell Carcinoma (cSCC) Patients at High Risk of Metastasis within Lower-Staged Tumors to Better Guide Treatment Decisions. J of Skin [Internet]. 2024 Mar. 18 [cited 2025 Apr. 19];8(2):s385. Available from: https://skin.dermsquared.com/skin/article/view/2591